Brit Mollenhauer, MD

Brit Mollenhauer

Brit Mollenhauer is a neurologist with over 10 years clinical expertise in Parkinson’s disease and movement disorders.

She also has a degree in neurochemistry. After her studies in neuroscience at Harvard Medical School, Cambridge, USA she became head of translational research at the Paracelsus-Elena Klinik (PEKK), which is the largest hospital for movement disorders in Germany with 120 beds and more than 3000 patients per year.

Dr.Brit Mollenhauer has developed a study center for clinical trials and translational research with close collaborations with the Michael J. Fox Foundation for Parkinson’s Research; the clinic is one of the 7 European recruitment centers for the PPMI study.

The following 4 research products highlight our experience and qualifications as a Research Center of Excellence


Amprion has some important news we need to share with you!

To improve patient access to the SYNTap® biomarker test (CSF), Amprion is reducing the self-pay price for tests with service dates on or after July 1, 2023.

Old self-pay price: $1500.00. New self-pay price: $995.00

Effective July 1, 2023, there is a New ABN (Advanced Beneficiary Notification) form for use when ordering the SYNTap® biomarker test (CSF) for patients on Medicare. Order Process

CPT/PLA – The SYNTap® test has been issued a dedicated PLA code to be used when billing: 0393U
We have applied to be a medicare provider and will soon be able to courtesy bill Medicare for your patients.